217 related articles for article (PubMed ID: 1848663)
21. The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
Kurokawa M; Mitani K; Imai Y; Ogawa S; Yazaki Y; Hirai H
Blood; 1998 Dec; 92(11):4003-12. PubMed ID: 9834202
[TBL] [Abstract][Full Text] [Related]
22. The EVI1 gene in myeloid leukemia.
Nucifora G
Leukemia; 1997 Dec; 11(12):2022-31. PubMed ID: 9447815
[TBL] [Abstract][Full Text] [Related]
23. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.
Goyama S; Kurokawa M
Cancer Sci; 2009 Jun; 100(6):990-5. PubMed ID: 19385966
[TBL] [Abstract][Full Text] [Related]
24. Alternative splicing of the Evi-1 zinc finger gene generates mRNAs which differ by the number of zinc finger motifs.
Bordereaux D; Fichelson S; Tambourin P; Gisselbrecht S
Oncogene; 1990 Jun; 5(6):925-7. PubMed ID: 2113669
[TBL] [Abstract][Full Text] [Related]
25. Analysis of proviruses integrated in Fli-1 and Evi-1 regions in Cas-Br-E MuLV-induced non-T-, non-B-cell leukemias.
Bergeron D; Poliquin L; Houde J; Barbeau B; Rassart E
Virology; 1992 Dec; 191(2):661-9. PubMed ID: 1448920
[TBL] [Abstract][Full Text] [Related]
26. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines.
Morishita K; Parker DS; Mucenski ML; Jenkins NA; Copeland NG; Ihle JN
Cell; 1988 Sep; 54(6):831-40. PubMed ID: 2842066
[TBL] [Abstract][Full Text] [Related]
27. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator.
Soderholm J; Kobayashi H; Mathieu C; Rowley JD; Nucifora G
Leukemia; 1997 Mar; 11(3):352-8. PubMed ID: 9067573
[TBL] [Abstract][Full Text] [Related]
28. Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins.
Palmer S; Brouillet JP; Kilbey A; Fulton R; Walker M; Crossley M; Bartholomew C
J Biol Chem; 2001 Jul; 276(28):25834-40. PubMed ID: 11328817
[TBL] [Abstract][Full Text] [Related]
29. Expression of the transcription factor Evi-1 in human erythroleukemia cell lines and in leukemias.
Fontenay-Roupie M; Bouscary D; Melle J; Viguié F; Picard F; Guesnu M; Dreyfus F
Hematol Cell Ther; 1997 Feb; 39(1):5-10. PubMed ID: 9088932
[TBL] [Abstract][Full Text] [Related]
30. Abnormal expression of Evi-1 gene in human leukemias.
Ogawa S; Mitani K; Kurokawa M; Matsuo Y; Minowada J; Inazawa J; Kamada N; Tsubota T; Yazaki Y; Hirai H
Hum Cell; 1996 Dec; 9(4):323-32. PubMed ID: 9183665
[TBL] [Abstract][Full Text] [Related]
31. Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells.
Arai S; Yoshimi A; Shimabe M; Ichikawa M; Nakagawa M; Imai Y; Goyama S; Kurokawa M
Blood; 2011 Jun; 117(23):6304-14. PubMed ID: 21190993
[TBL] [Abstract][Full Text] [Related]
32. Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3.
Khanna-Gupta A; Lopingco MC; Savinelli T; Zibello T; Berliner N; Perkins AS
Oncogene; 1996 Feb; 12(3):563-9. PubMed ID: 8637713
[TBL] [Abstract][Full Text] [Related]
33. Unique expression of the human Evi-1 gene in an endometrial carcinoma cell line: sequence of cDNAs and structure of alternatively spliced transcripts.
Morishita K; Parganas E; Douglass EC; Ihle JN
Oncogene; 1990 Jul; 5(7):963-71. PubMed ID: 2115646
[TBL] [Abstract][Full Text] [Related]
34. The Evi-1 zinc finger myeloid transforming gene is normally expressed in the kidney and in developing oocytes.
Morishita K; Parganas E; Parham DM; Matsugi T; Ihle JN
Oncogene; 1990 Sep; 5(9):1419-23. PubMed ID: 1699199
[TBL] [Abstract][Full Text] [Related]
35. Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR.
Boyd KE; Xiao YY; Fan K; Poholek A; Copeland NG; Jenkins NA; Perkins AS
Blood; 2006 Jan; 107(2):733-41. PubMed ID: 16204320
[TBL] [Abstract][Full Text] [Related]
36. Expression and regulation of the evi-1 gene in the human factor-dependent leukemia cell line, UCSD/AML1.
Oval J; Smedsrud M; Taetle R
Leukemia; 1992 May; 6(5):446-51. PubMed ID: 1593910
[TBL] [Abstract][Full Text] [Related]
37. Evi-2, a common integration site involved in murine myeloid leukemogenesis.
Buchberg AM; Bedigian HG; Jenkins NA; Copeland NG
Mol Cell Biol; 1990 Sep; 10(9):4658-66. PubMed ID: 2167436
[TBL] [Abstract][Full Text] [Related]
38. Retroviral integration in murine myeloid tumors to identify Evi-1, a novel locus encoding a zinc-finger protein.
Copeland NG; Jenkins NA
Adv Cancer Res; 1990; 54():141-57. PubMed ID: 2105003
[No Abstract] [Full Text] [Related]
39. Carbon tetrachloride induction of rapid changes in liver nuclear protein factors capable of sequence-specific binding to regulatory elements in the long terminal repeat of polytropic-class endogenous murine leukemia virus-related proviruses.
Hoyt PR; Wang TH; Henley DC; Yang DM; Ch'ang LY; Yang WK
Mol Carcinog; 1993; 8(4):245-54. PubMed ID: 8280373
[TBL] [Abstract][Full Text] [Related]
40. Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein.
Gilks CB; Bear SE; Grimes HL; Tsichlis PN
Mol Cell Biol; 1993 Mar; 13(3):1759-68. PubMed ID: 8441411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
